Liver transplantation for incidental cholangiocarcinoma: Analysis of the Canadian experience

Liver Transplantation

Volumn 11, Issue 11, 2005, Pages 1412-1416

  Ghali, Peter ^a   Marotta, Paul J ^b   Yoshida, Eric M ^c   Bain, Vincent G ^d   Marleau, Denis ^e   Peltekian, Kevork ^f   Metrakos, Peter ^a   Deschênes, Marc ^a,g  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; BILE DUCT CARCINOMA; CANADA; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DEATH; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CANADA; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INCIDENTAL FINDINGS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 30444461517     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20512     Document Type: Review

References (16)

1. Yeo CJ, Pitt HA, Cameron JL. Cholangiocarcinoma. Surg Clin North Am 1990;70:1429-1447.
2. de Groen PC, Gores GJ, LaRusso NF. Biliary tract cancers. N Engl J Med 1999;341:1368-1378.
3. Lindner P, Norrby J, Olausson M. Survival after liver transplantation for cholangiocarcinoma has increased during the last decade. Transpl Proc 2003;35:811-812.
4. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69: 1633-1637.
5. Shimoda M, Farmer DG, Colquhoun SD. Liver transplantation for cholangiocellular carcinoma: analysis of a single-centre experience and review of the literature. Liver Transpl 2001;7:1023-1033.
6. Weimann A, Varnholt H, Schlitt HJ. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg 2000;87:1182-1187.
7. Jeyarajah DR, Klintmalm GB. Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg 1995;5: 48-51.
8. Goldstein RM, Stone M, Tillery GW. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993;166:766-771.
9. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 110:726-734.
10. Ringe B, Wittekind C, Bechstein WO. The role of liver transplantation in hepatobiliary malignancy. Ann Surg 1988;209:88-98.
11. De Vreede I, Steers JL, Burch PA. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000;6:309-316.
12. Goss JA, Shackleton CR, Farmer DG. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single centre experience. Ann Surg 1997;225:472-481.
13. Broome U, Olsson R, Loof L. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-615.
14. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997.
15. Loinaz C, Abradelo M, Gomez R. Liver transplantation and incidental primary liver tumors. Transpl Proc 1998;30:3301-3302.
16. Abu-Elmagd KM, Malinchoc M, Dickson ER, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993;177:335-344.